Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - felv recombinant canarypox virus (vcp97); attenuated feline panleucopenia virus (pli iv); attenuated chlamydophila felis (905 strain); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - felv recombinant canarypox virus (vcp97) 0,00 ly.insp.sv 0; attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; attenuated chlamydophila felis (905 strain) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 0,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia + feline leukaemia recombinant live canarypox virus - Γάτες - Χρόνοι αναμονής: Γάτες

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

virbac s.a., carros, france (0000006112) 1 avenue 2065,,m-lid 06516 carros,fr - live attenuated feline panleucopenia virus (strain lr 72); live attenuated feline viral rhinotracheitis virus (strain f2); quillaja saponaria; aluminium hydroxide gel; purified p 45 felv envelope antigen; live feline calicivirus (fcv) strain f9 - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΕΝΕΣΙΜΟΥ ΕΝΑΙΩΡΗΜΑΤΟΣ - Λυοφιλοποιημένο υλικό και εναιώρημα για παρασκευή ενεσίμου εναιωρήματος - live attenuated feline panleucopenia virus (strain lr 72) 0,00 ly.sus.inj 0; live attenuated feline viral rhinotracheitis virus (strain f2) 0,00 ly.sus.inj 0; quillaja saponaria 10,00 ly.sus.inj 0; aluminium hydroxide gel 1,00 ly.sus.inj 0; purified p 45 felv envelope antigen 102,00 ly.sus.inj 0; live feline calicivirus (fcv) strain f9 0,00 ly.sus.inj 0 - live feline panleucopenia virus / parvovirus + live feline rhinotracheitis virus + live feline calicivirus + inactivated feline leukaemia virus - Γάτες - Χρόνοι αναμονής: Γάτες

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - attenuated feline panleucopenia virus (pli iv); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 2,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + live feline panleucopenia virus / parvovirus + inactivated feline calicivirus antigen - Γάτες - Χρόνοι αναμονής: Γάτες

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΚΑΝΔΗΛΙΔΗ Α.Ε. Δ.Τ. candilidis sa (0000014548) Λεωφ. Κύμης & Ηλέκτρας 4β,15122,Μαρούσι, Αττική,gr - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain); attenuated feline panleucopenia virus (pli iv); inactivated feline calicivirus, strain 255 - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - - - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 em.inj -; attenuated feline panleucopenia virus (pli iv) 0,00 em.inj -; inactivated feline calicivirus, strain 255 0,00 em.inj - - feline rhinotracheitis virus + feline calicivirus + feline panleucopenia virus / parvovirus - Γάτες - Χρόνοι αναμονής: Γάτες

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

ΚΑΝΔΗΛΙΔΗ Α.Ε. Δ.Τ. candilidis sa (0000014548) Λεωφ. Κύμης & Ηλέκτρας 4β,15122,Μαρούσι, Αττική,gr - rabies virus, strain sad vnukovo-32; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain); inactivated feline calicivirus, strain 255; attenuated feline panleucopenia virus (pli iv) - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - - - rabies virus, strain sad vnukovo-32 0,00 em.inj -; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 em.inj -; inactivated feline calicivirus, strain 255 0,00 em.inj -; attenuated feline panleucopenia virus (pli iv) 0,00 em.inj - - feline panleucopenia virus + feline calcivirus + feline rhinotracheitis virus + rabies virus - Γάτες - Χρόνοι αναμονής: Γάτες

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

zoetis hellas s.a. (0000010752) Φραγκοκκλησιάς 7,151 25,Μαρούσι Αττικής,gr - ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ ΤΗΣ ΓΆΤΑΣ chlamydophyla felis ΑΠΌΘΕΜΑ ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ ΤΗΣ ΙΟΓΕΝΟΎΣ rhinotraheitis ΙΌ ΑΠΌΘΕΜΑ ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ ΤΟΥ ΚΑΛΥΚΟΪΟΎ ΤΗΣ ΓΆΤΑΣ ΑΠΌΘΕΜΑ ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ ΤΗΣ ΠΑΝΛΕΥΚΟΠΕΝΊΑΣ ΤΗΣ ΓΆΤΑΣ, vires ΑΠΌΘΕΜΑ - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - inactivated feline chlamydophyla felis stock 0,10 inj.susp 0; inactivated feline viral rhinotraheitis virus stock 0,10 inj.susp 0; inactivated feline calicivirus stock 0,05 inj.susp 0; inactivated feline panleukopenia vires stock 0,20 inj.susp 0 - feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + inactivated chlamydia - Γάτες - Χρόνοι αναμονής: Γάτες

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. Οι αντιδράσεις ανοσίας έχουν αποδειχθεί μία εβδομάδα μετά την αρχική πορεία εμβολιασμού για ρινοτραχειίτιδα, καλυκοϊό, συστατικά chlamydophila felis και παγκρεακοπενία. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.